March 9 (Reuters) - Prescient Therapeutics Ltd (PTX) :
- U.S. FDA GRANTS PTX-100 ADDITIONAL ORPHAN DRUG DESIGNATION (ODD) FOR ALL T CELL LYMPHOMAS
March 9 (Reuters) - Prescient Therapeutics Ltd (PTX) : U.S. FDA...
Add to My Watchlist
What is My Watchlist?